Stephen Murray
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Cancer Research top 10%
- Carcinogens and Genotoxicity Assessment
Papers in
-
- Pharmacogenetics and Drug Metabolism 8
- Drug-Induced Hepatotoxicity and Protection 2
-
- RNA modifications and cancer 2
- Co-authors
- Alan R. Boobis (11 shared papers)Robert J. Edwards (3 shared papers)Donald S. Davies (6 shared papers)Nigel J. Gooderham (4 shared papers)Anthony M. Lynch (2 shared papers)Shinichi Kobayashi (1 shared paper)D. S. Davies (1 shared paper)David G. Watson (1 shared paper)
- Journals
- Biochemical Pharmacology (3 papers)Carcinogenesis (2 papers)Toxicology and Applied Pharmacology (1 paper)British Journal of Clinical Pharmacology (1 paper)Critical Reviews in Oncology/Hematology (1 paper)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Stephen Murray
16 papers receiving 623 citations
Peers
Comparison fields: 5 of 76
- Pharmacology 303
- Cancer Research 176
- Health, Toxicology and Mutagenesis 101
- Biochemistry 47
- Oncology 157
Countries citing papers authored by Stephen Murray
This map shows the geographic impact of Stephen Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Murray more than expected).
Fields of papers citing papers by Stephen Murray
This network shows the impact of papers produced by Stephen Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Murray. The network helps show where Stephen Murray may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Murray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 117 | |
| 2 | Intra- and interindividual variability in systemic exposure in humans to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline and 2-amino-1-methyl- 6-phenylimidazo[4,5-b]pyridine, carcinogens present in cooked beef. | 1992 | 110 |
| 3 | 2001 | 82 | |
| 4 | 2001 | 77 | |
| 5 | 1993 | 63 | |
| 6 | 1985 | 57 | |
| 7 | 1993 | 29 | |
| 8 | 2005 | 22 | |
| 9 | 2000 | 19 | |
| 10 | 1995 | 19 | |
| 11 | Relationship between oxidative metabolism of 2-acetylaminofluorene, debrisoquine, bufuralol, and aldrin in human liver microsomes. | 1984 | 18 |
| 12 | 2001 | 13 | |
| 13 | 1993 | 9 | |
| 14 | 2001 | 4 | |
| 15 | 1996 | 2 | |
| 16 | 2005 | 1 |
About Stephen Murray
Stephen Murray is a scholar working on Pharmacology, Molecular Biology, Oncology, Cancer Research and Health, Toxicology and Mutagenesis, having authored 16 papers that have together received 642 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (8 papers), Carcinogens and Genotoxicity Assessment (5 papers), Drug Transport and Resistance Mechanisms (3 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Analytical Chemistry and Chromatography (2 papers), Indoor Air Quality and Microbial Exposure (2 papers), Synthesis and Biological Evaluation (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Pharmacology (303 citations), Cancer Research (176 citations), Health, Toxicology and Mutagenesis (101 citations), Biochemistry (47 citations) and Oncology (157 citations). Stephen Murray has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Alan R. Boobis, Robert J. Edwards, Donald S. Davies, Nigel J. Gooderham, Anthony M. Lynch, Shinichi Kobayashi, D. S. Davies, David G. Watson, Mark G. Knize and D. S. Davies. Their work appears in journals such as Biochemical Pharmacology, Carcinogenesis, Toxicology and Applied Pharmacology, British Journal of Clinical Pharmacology and Critical Reviews in Oncology/Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.